Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Net Assets
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has net assets worth CN¥2.08 Billion CNY (≈ $304.67 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.80 Billion ≈ $409.67 Million USD) and total liabilities (CN¥717.55 Million ≈ $105.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 605016 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.08 Billion |
| % of Total Assets | 74.37% |
| Annual Growth Rate | 20.63% |
| 5-Year Change | 62.99% |
| 10-Year Change | N/A |
| Growth Volatility | 18.74 |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Net Assets Trend (2016–2025)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. See 605016 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the annual net assets of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025. For live valuation and market cap data, see Shandong Bailong Chuangyuan Bio-Tech Co. market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.96 Billion ≈ $287.02 Million |
+16.81% |
| 2024-12-31 | CN¥1.68 Billion ≈ $245.73 Million |
+11.37% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.64 Million |
+12.11% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
+11.76% |
| 2021-12-31 | CN¥1.20 Billion ≈ $176.10 Million |
+74.14% |
| 2020-12-31 | CN¥691.09 Million ≈ $101.13 Million |
+15.75% |
| 2019-12-31 | CN¥597.07 Million ≈ $87.37 Million |
+19.01% |
| 2018-12-31 | CN¥501.71 Million ≈ $73.42 Million |
+14.96% |
| 2017-12-31 | CN¥436.41 Million ≈ $63.86 Million |
+20.33% |
| 2016-12-31 | CN¥362.67 Million ≈ $53.07 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5702.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.05 Billion | 53.32% |
| Other Components | CN¥915.55 Million | 46.68% |
| Total Equity | CN¥1.96 Billion | 100.00% |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Market Cap
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Poly Plastic Masterbatch Suzhou Co
SHE:300905
|
$1.55 Billion |
|
Xinjiang Zhongtai Chemical Co Ltd
SHE:002092
|
$1.55 Billion |
|
Alkane Resources Ltd
AU:ALK
|
$1.55 Billion |
|
Yinbang Clad Material
SHE:300337
|
$1.55 Billion |
|
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
|
$1.55 Billion |
|
Vaisala Oyj A
HE:VAIAS
|
$1.54 Billion |
|
Triumph Financial, Inc.
NYSE:TFIN
|
$1.54 Billion |
|
Yutong Optical
SHE:300790
|
$1.54 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,679,237,143 to 1,961,465,972, a change of 282,228,829 (16.8%).
- Net income of 368,550,235 contributed positively to equity growth.
- Dividend payments of 92,821,543 reduced retained earnings.
- Other comprehensive income decreased equity by 120,032,949.
- Other factors increased equity by 126,533,086.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥368.55 Million | +18.79% |
| Dividends Paid | CN¥92.82 Million | -4.73% |
| Other Comprehensive Income | CN¥-120.03 Million | -6.12% |
| Other Changes | CN¥126.53 Million | +6.45% |
| Total Change | CN¥- | 16.81% |
Book Value vs Market Value Analysis
This analysis compares Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.39x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 11.01x to 5.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥2.28 | CN¥25.15 | x |
| 2017-12-31 | CN¥2.34 | CN¥25.15 | x |
| 2018-12-31 | CN¥2.69 | CN¥25.15 | x |
| 2019-12-31 | CN¥3.28 | CN¥25.15 | x |
| 2020-12-31 | CN¥3.88 | CN¥25.15 | x |
| 2021-12-31 | CN¥6.75 | CN¥25.15 | x |
| 2022-12-31 | CN¥5.41 | CN¥25.15 | x |
| 2023-12-31 | CN¥4.69 | CN¥25.15 | x |
| 2024-12-31 | CN¥5.20 | CN¥25.15 | x |
| 2025-12-31 | CN¥4.67 | CN¥25.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.79%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 26.72%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.24x
- Recent ROE (18.79%) is above the historical average (13.93%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 17.87% | 19.31% | 0.53x | 1.74x | CN¥28.53 Million |
| 2017 | 14.60% | 20.52% | 0.50x | 1.43x | CN¥20.09 Million |
| 2018 | 13.02% | 18.37% | 0.58x | 1.22x | CN¥15.13 Million |
| 2019 | 13.86% | 19.66% | 0.56x | 1.26x | CN¥23.08 Million |
| 2020 | 13.83% | 19.12% | 0.60x | 1.21x | CN¥26.44 Million |
| 2021 | 8.68% | 15.99% | 0.51x | 1.07x | CN¥-15.87 Million |
| 2022 | 11.21% | 20.88% | 0.49x | 1.09x | CN¥16.26 Million |
| 2023 | 12.80% | 22.23% | 0.49x | 1.16x | CN¥42.21 Million |
| 2024 | 14.63% | 21.33% | 0.57x | 1.20x | CN¥77.67 Million |
| 2025 | 18.79% | 26.72% | 0.57x | 1.24x | CN¥172.40 Million |
Industry Comparison
This section compares Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,082,192,569
- Average return on equity (ROE) among peers: 2.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) | CN¥2.08 Billion | 17.87% | 0.34x | $1.55 Billion |
| Shenzhen Shenbao Industrial Co Ltd (000019) | $372.94 Million | 1.53% | 0.77x | $992.25 Million |
| Hainan Pearl River Holdings Co Ltd (000505) | $399.64 Million | -9.56% | 0.79x | $515.34 Million |
| Xiwang Foodstuffs Co Ltd (000639) | $135.06 Million | 5.79% | 0.97x | $206.92 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $199.49 Million | -32.62% | 2.81x | $473.73 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $796.52 Million | 0.36% | 0.09x | $400.45 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $16.36 Billion | 24.69% | 0.34x | $11.55 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $767.56 Million | 1.47% | 1.57x | $388.25 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $405.77 Million | 18.27% | 1.07x | $599.98 Million |
| Qingdao Foods Co Ltd (001219) | $923.11 Million | 9.90% | 0.10x | $351.80 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $461.01 Million | 8.31% | 0.83x | $507.38 Million |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more